Document:

ex10-2.htm

Exhibit 10.2

     

    
 

    THIS
NOTE AND THE COMMON SHARES ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.  THIS NOTE
AND THE COMMON SHARES ISSUABLE UPON CONVERSION OF THIS NOTE MAY NOT BE SOLD,
OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE
REGISTRATION STATEMENT AS TO THIS NOTE OR THE COMMON SHARES
ISSUABLE UPON CONVERSION OF THE NOTE UNDER SAID ACT OR AN OPINION OF COUNSEL
REASONABLY SATISFACTORY TO OMNIMMUNE HOLDINGS, INC. THAT SUCH REGISTRATION IS
NOT REQUIRED.

     

                                                                                                

    
    

     

    
      	Principal Amount:
      $_____________ 	Issue Date: January
      __, 2010
	 	 

    

     

    
 

    CONVERTIBLE
NOTE

    

    FOR VALUE
RECEIVED, OMNIMMUNE HOLDINGS, INC., a Delaware corporation (hereinafter called
"Borrower"), hereby promises to pay to ____________, ___________, ________,
_______, telecopier _____________ (the “Holder”), or order, without demand, the
sum of _____________ Dollars ($____________), with simple interest accruing
thereon, on the fifth anniversary of the issuance of the first Note of like
tenor} (the "Maturity Date"), if not paid sooner.

    

    This Note
has been entered into pursuant to the terms of a subscription agreement between
the Borrower and the Holder, dated of even date herewith (the “Subscription
Agreement”), and shall be governed by the terms of such Subscription
Agreement.  Unless otherwise separately defined herein, all
capitalized terms used in this Note shall have the same meaning as is set forth
in the Subscription Agreement.  The following terms shall apply to
this Note:

    

    ARTICLE
I

    

    GENERAL
PROVISIONS

    

    1.1           Payment Grace
Period.  The Borrower shall have a ten (10) business day grace
period to pay any monetary amounts due under this Note, after which grace period
and during the pendency of an Event of Default (as defined in Article III) a
default interest rate of twelve percent (12%) per annum shall apply to the
amounts owed hereunder.

    

    1.2           Conversion
Privileges.  The Conversion Privileges set forth in Article II
shall remain in full force and effect immediately from the date hereof and until
the Note is paid in full regardless of the occurrence of an Event of
Default.  The Note shall be payable in full on the Maturity Date,
unless previously converted into Common Stock in accordance with Article II
hereof; provided, that if an Event of Default has occurred that has not been
timely cured, the Holder may extend the Maturity Date an amount of time equal to
the duration of the Event of Default.

    

    1.3           Interest
Rate.   Simple interest payable on this Note shall accrue
at the annual rate of ten percent (10%) and be payable at the request of the
Holder upon or after each conversion of principal pursuant to Article II, and on
the Maturity Date, accelerated or otherwise, when the principal and remaining
accrued but unpaid interest shall be due and payable, or sooner as described
below.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    ARTICLE
II

    

    CONVERSION
RIGHTS

    

    The
Holder shall have the right to convert the principal due under this Note into
Shares of the Borrower's Common Stock, $0.0001 par value per share (“Common
Stock”) as set forth below.

    

    2.1.           Conversion into the
Borrower's Common Stock.

    

    (a)           The
Holder shall have the right from and after the issuance of this Note and then at
any time until this Note is fully paid, to convert any outstanding and unpaid
principal portion of this Note, at the election of the Holder (the date of
giving of such notice of conversion being a "Conversion Date") into fully paid
and nonassessable shares of Common Stock as such stock exists on the date of
issuance of this Note, or any shares of capital stock of Borrower into which
such Common Stock shall hereafter be changed or reclassified, at the conversion
price as defined in Section 2.1(b) hereof (the "Conversion Price"), determined
as provided herein.  Upon delivery to the Borrower of a completed
Notice of Conversion, a form of which is annexed hereto, Borrower shall issue
and deliver to the Holder within three (3) business days after the Conversion
Date (such third day being the “Delivery Date”) that number of shares of Common
Stock for the portion of the Note converted in accordance with the
foregoing.  The number of shares of Common Stock to be issued upon
each conversion of this Note shall be determined by dividing that portion of the
principal of the Note to be converted, by the Conversion Price.

    

    (b)           Subject
to adjustment as provided in Section 2.1(c) hereof, the Conversion Price per
share shall be $0.01.

    

    (c)           
The Conversion Price and number and kind of shares or other securities to be
issued upon conversion determined pursuant to Section 2.1(a), shall be subject
to adjustment from time to time upon the happening of certain events while this
conversion right remains outstanding, as follows:

    

    A.           Merger,
Sale of Assets, etc.  If the Borrower at any time shall consolidate
with or merge into or sell or convey all or substantially all its assets to any
other corporation, this Note, as to the unpaid principal portion thereof and
accrued interest thereon, shall thereafter be deemed to evidence the right to
purchase such number and kind of shares or other securities and property as
would have been issuable or distributable on account of such consolidation,
merger, sale or conveyance, upon or with respect to the securities subject to
the conversion or purchase right immediately prior to such consolidation,
merger, sale or conveyance.  The foregoing provision shall similarly
apply to successive transactions of a similar nature by any such successor or
purchaser.  Without limiting the generality of the foregoing, the
anti-dilution provisions of this Section shall apply to such securities of such
successor or purchaser after any such consolidation, merger, sale or
conveyance.

    

    B.           Reclassification,
etc.  If the Borrower at any time shall, by reclassification or
otherwise, change the Common Stock into the same or a different number of
securities of any class or classes that may be issued or outstanding, this Note,
as to the unpaid principal portion thereof and accrued interest thereon, shall
thereafter be deemed to evidence the right to purchase an adjusted number of
such securities and kind of securities as would have been issuable as the result
of such change with respect to the Common Stock immediately prior to such
reclassification or other change.

    

    C.           Stock
Splits, Combinations and Dividends.  If the shares of Common Stock are
subdivided or combined into a greater or smaller number of shares of Common
Stock, or if a dividend is paid on the Common Stock in shares of Common Stock,
the Conversion Price shall be proportionately reduced in case of subdivision of
shares or stock dividend or proportionately increased in the case of combination
of shares, in each such case by the ratio which the total number of shares of
Common Stock outstanding immediately after such event bears to the total number
of shares of Common Stock outstanding immediately prior to such
event.

     

    (d)           Whenever
the Conversion Price is adjusted pursuant to Section 2.1(c) above, the Borrower
shall promptly mail to the Holder a notice setting forth the Conversion Price
after such adjustment and setting forth a statement of the facts requiring such
adjustment.

    

    (e)           Subject
to availability of sufficient authorized and unissued shares of Common Stock,
Borrower will reserve from its authorized and unissued Common Stock the number
of shares of Common Stock during the time periods and in the amounts described
in the Subscription Agreement.  Borrower represents that upon
issuance, such shares will be duly and validly issued, fully paid and
non-assessable.  Borrower agrees that its issuance of this Note shall
constitute full authority to its officers, agents, and transfer agents who are
charged with the duty of executing and issuing stock certificates to execute and
issue the necessary certificates for shares of Common Stock upon the conversion
of this Note.

    

    2.2           Method of
Conversion.  This Note may be converted by the Holder in whole
or in part as described in Section 2.1(a) hereof and the Subscription
Agreement.  Upon partial conversion of this Note, a new Note
containing the same date and provisions of this Note shall, at the request of
the Holder, be issued by the Borrower to the Holder for the principal balance of
this Note and interest which shall not have been converted or paid.

    

    2.3           Maximum
Conversion.  The Holder shall not be entitled to convert on a
Conversion Date that amount of the Note in connection with that number of shares
of Common Stock which would be in excess of the number of shares of Common Stock
which would result in beneficial ownership by the Holder and its affiliates of
more than 4.99% of the outstanding shares of Common Stock of the Borrower on
such Conversion Date.  For the purposes of the provision to the
immediately preceding sentence, beneficial ownership shall be determined in
accordance with Section 13(d) of the Securities Exchange Act of 1934, as
amended, and Regulation 13d-3 thereunder.  Subject to the foregoing,
the Holder shall not be limited to aggregate conversions of only 4.99% and
aggregate conversion by the Holder may exceed 4.99%.  The Holder shall
have the authority and obligation to determine whether the restriction contained
in this Section 2.3 will limit any conversion hereunder and to the extent that
the Holder determines that the limitation contained in this Section applies, the
determination of which portion of the Notes are convertible shall be the
responsibility and obligation of the Holder.  The Holder may waive the
conversion limitation described in this Section 2.3, in whole or in part, upon
and effective after 61 days prior written notice to the Borrower to increase
such percentage to up to 9.99%.  The Holder may allocate which of the
equity of the Borrower deemed beneficially owned by the Holder shall be included
in the 4.99% amount or up to 9.99% amount as described above.

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    2.4.  Limitation
on Conversion Rights.  Holder acknowledges and understands that,
unless and until there is an increase in the authorized share capital of the
Company, the number of shares of Common Stock into which all outstanding options, warrants and
convertible securities would be convertible upon consummation of the
transactions contemplated by the Subscription Agreement and the Term Sheet (as
defined in the Subscription Agreement) would substantially exceed the total
number of currently authorized shares of the Company.  Accordingly,
pending an increase in authorized share capital, there may not be sufficient
authorized shares available for issuance upon receipt by the Company of a
request for conversion of the Notes.    Notwithstanding any
other provision hereof or of the Subscription Agreement, Holder agrees and
acknowledges that the right to convert shall be subject to the availability of a
sufficient number of authorized and unissued shares of Commons Stock of the
Company  to accommodate the conversion as measured at the time a
request for conversion is made.

     

     

    ARTICLE
III

    

    EVENT
OF DEFAULT

    

    The
occurrence of any of the following events of default ("Event of Default") shall,
at the option of the Holder hereof, make all sums of principal and interest then
remaining unpaid hereon and all other amounts payable hereunder immediately due
and payable, upon demand, without presentment, or grace period, all of which
hereby are expressly waived, except as set forth below:

    

    3.1           Failure to Pay Principal or
Interest.  The Borrower fails to pay any installment of
principal, interest or other sum due under this Note when due and such failure
continues for a period of ten (10) business days after the due
date.  The ten (10) day period described in this Section 3.1 is the
same ten (10) business day period described in Section 1.1 hereof.

    

    3.2           Breach of
Covenant.  The Borrower breaches any material covenant or other
material term or condition of the Subscription Agreement or this Note in any
material respect and such breach, if subject to cure, continues for a period of
ten (10) business days after written notice to the Borrower from the
Holder.

    

    3.3           Breach of Representations
and Warranties.  Any material representation or warranty of the
Borrower made herein, in the Subscription Agreement, or in any agreement,
statement or certificate given in writing pursuant hereto or in connection
therewith shall be false or misleading in any material respect as of the date
made and the Closing Date.

    

    3.4           Receiver or
Trustee.  The Borrower shall make an assignment for the benefit
of creditors, or apply for or consent to the appointment of a receiver or
trustee for it or for a substantial part of its property or business; or such a
receiver or trustee shall otherwise be appointed without the consent of the
Borrower is not dismissed within sixty (60) days of appointment.

    

    3.5           Judgments.  Any
money judgment, writ or similar final process or non-appealable order of final
judgment shall be entered or filed against Borrower or any of its property or
other assets for more than $150,000, and shall remain unpaid, unvacated,
unbonded or unstayed for a period of forty-five (45) days.

    

    3.6           Bankruptcy.  Bankruptcy,
insolvency, reorganization or liquidation proceedings or other proceedings or
relief under any bankruptcy law or any law, or the issuance of any notice in
relation to such event, for the relief of debtors shall be instituted by or
against the Borrower and if instituted against Borrower are not dismissed within
sixty (60) days of initiation.

    

    3.7          
 Delisting.   Failure
of the Common Stock to be listed for trading or quotation on a Principal Market,
which delisting remains uncured for ten or more consecutive days.

    

    3.8           Non-Payment.   A
default by the Borrower, occurring following the Issue Date,  under
any one or more obligations in an aggregate monetary amount in excess of
$200,000 for more than forty-five (45) days after the due date, unless the
Borrower is contesting the validity of such obligation in good faith, or except
as described on Schedule 5(q) to the Subscription Agreement, or except for
obligations where the Borrower and creditor have agreed to alternative payment
terms.  This provision shall not apply with respect to any purported
obligation under the Company’s license agreement with Ohio State University, as
described in the Company’s public filings.

    

    3.9           Stop
Trade.  An SEC or judicial stop trade order or Principal Market
trading suspension that lasts for ten or more consecutive trading
days.

    

    3.10          Failure to Deliver Common
Stock or Replacement Note.  Subject to Section 2.4 hereof,
Borrower's failure to timely deliver Common Stock to the Holder pursuant to and
in the form required by this Note and Sections 7 and 11 of the Subscription
Agreement, or, if required, a replacement Note for ten business days beyond the
required delivery date or any stated cure period, whichever is
later.

    

    3.11          Reservation
Default.   Subject to Section 2.4 hereof , failure by the
Borrower to have reserved for issuance upon conversion of the Note the amount of
Common Stock as set forth in this Note.

    

    3.12          Cross
Default.  A default by the Borrower of a material term,
covenant, warranty or undertaking of any other agreement to which the Borrower
and Holder are parties, if any, or the occurrence of a material event of default
under any such other agreement which is not cured after any required notice
and/or cure period.

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    ARTICLE
IV

     

    MISCELLANEOUS

    

    4.1           Failure or Indulgence Not
Waiver.  No failure or delay on the part of Holder hereof in
the exercise of any power, right or privilege hereunder shall operate as a
waiver thereof, nor shall any single or partial exercise of any such power,
right or privilege preclude other or further exercise thereof or of any other
right, power or privilege.  All rights and remedies existing hereunder
are cumulative to, and not exclusive of, any rights or remedies otherwise
available.

    

    4.2           Notices.  All
notices, demands, requests, consents, approvals, and other communications
required or permitted hereunder shall be in writing and, unless otherwise
specified herein, shall be (i) personally served, (ii) deposited in the mail,
registered or certified, return receipt requested, postage prepaid, (iii)
delivered by reputable air courier service with charges prepaid, or (iv)
transmitted by hand delivery, telegram, or facsimile, addressed as set forth
below or to such other address as such party shall have specified most recently
by written notice.  Any notice or other communication required or
permitted to be given hereunder shall be deemed effective (a) upon hand delivery
or delivery by facsimile, with accurate confirmation generated by the
transmitting facsimile machine, at the address or number designated below (if
delivered on a business day during normal business hours where such notice is to
be received), or the first business day following such delivery (if delivered
other than on a business day during normal business hours where such notice is
to be received) or (b) on the second business day following the date of mailing
by express courier service, fully prepaid, addressed to such address, or upon
actual receipt of such mailing, whichever shall first occur.  The
addresses for such communications shall be: (i) if to the Borrower to: Omnimmune
Holdings, Inc., 4600 Post Oak Place, Suite 352, Houston, TX , Attn: Harris A.
Lichtenstein, CEO, telecopier: (713) 622-8401, with a copy by telecopier only
to: Anslow + Jaclin LLP, 195 Route 9 South, Manalapan, NJ 07726, Attn: Eric
Stein, Esq., telecopier: (732) 577-1188, and (ii) if to the Holder, to the name,
address and telecopy number set forth on the front page of this Note, with a
copy by telecopier only to Andrew J. Levinson, 1350 Broadway, 11th
Floor, New York, New York 10018, telecopier number: (646) 390-6307.

    

    4.3           Amendment
Provision.  The term "Note" and all reference thereto, as used
throughout this instrument, shall mean this instrument as originally executed,
or if later amended or supplemented, then as so amended or
supplemented.

    

    4.4           Assignability.  This
Note shall be binding upon the Borrower and its successors and assigns, and
shall inure to the benefit of the Holder and its successors and
assigns.

    

    4.5           Cost of
Collection.  If default is made in the payment of this Note,
Borrower shall pay the Holder hereof reasonable costs of collection, including
reasonable attorneys' fees.

    

    4.6           Governing
Law.  This Note shall be governed by and construed in
accordance with the laws of the State of New York.  Any action brought
by either party against the other concerning the transactions contemplated by
this Agreement shall be brought only in the civil or state courts of New York or
in the federal courts located in the State and county of New
York.  Both parties and the individual signing this Agreement on
behalf of the Borrower agree to submit to the jurisdiction of such
courts.  The prevailing party shall be entitled to recover from the
other party its reasonable attorney's fees and costs.

    

    4.7           Maximum
Payments.  Nothing contained herein shall be deemed to
establish or require the payment of a rate of interest or other charges in
excess of the maximum permitted by applicable law.  In the event that
the rate of interest required to be paid or other charges hereunder exceed the
maximum permitted by such law, any payments in excess of such maximum shall be
credited against amounts owed by the Borrower to the Holder and thus refunded to
the Borrower.

    

    4.8           Shareholder
Status.  The Holder shall not have rights as a shareholder of
the Borrower with respect to unconverted portions of this
Note.  However, the Holder will have all the rights of a shareholder
of the Borrower with respect to the shares of Common Stock to be received by
Holder after delivery by the Holder of a Conversion Notice to the
Borrower.

    

    IN WITNESS WHEREOF, Borrower
has caused this Note to be signed in its name by an authorized officer as of the
____ day of January 2010.

    

     

    OMNIMMUNE
HOLDINGS, INC.

    

    

    

    By:________________________________

    Name:

    Title:

    

    WITNESS:

     

    ______________________________________

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    NOTICE OF
CONVERSION

    

    (To be
executed by the Registered Holder in order to convert the Note)

    

    

    The
undersigned hereby elects to convert $_________ of the principal and $_________
of the interest due on the Note issued by Omnimmune Holdings, Inc. on January
__, 2010 into Shares of Common Stock of Omnimmune Holdings, Inc. (the
"Borrower") according to the conditions set forth in such Note, as of the date
written below.

    

    

    

    Date of
Conversion:___________________________________________________________________

    

    Conversion
Price:_____________________________________________________________________

    

    

    Shares To
Be
Delivered:________________________________________________________________

    

    

    Signature:___________________________________________________________________________

    

    

    Print
Name:__________________________________________________________________________

    

    

    Address:____________________________________________________________________________

    

       ___________________________________________________________________________ex10-3.htm

    Exhibit 10.3

    
 

    Omnimmune
Holdings, Inc.

    Term
Sheet for Debt Financing

    and
Agreed Upon  Restructuring

    

    January
13, 2010

    

    

    
      	
              Issuer

            	
              Omnimmune
      Holdings, Inc. (the “Company”).

            
	
              Security

            	
              Unsecured
      promissory notes (the “Notes”) in substantially the form attached hereto
      as Schedule A, bearing interest at 10% per annum, payable semi-annually in
      cash or additional notes of like tenor.  The Notes will mature
      five years after the first issuance of any Note.

            
	
              Conversion
      Feature of Notes

            	
              The
      Notes will be convertible, at one time or from time to time, into common
      stock of the Company at $.01 per share, subject to applicable adjustments
      to account for any technical corporate actions including stock splits,
      stock dividends, mergers, reorganizations or
      recapitalizations.  The conversion privilege shall specify that
      no conversion shall be allowed if (i) it will cause the holder of the Note
      being converted to beneficially own more than 4.99% of the Company’s
      common stock, calculated in accordance with rules of the Securities and
      Exchange Commission (the “SEC”) pursuant to Section 13(d) of the
      Securities Exchange Act, as amended (the Act”), or (ii) there is not a
      sufficient number of authorized and unissued shares of Common Stock to
      accommodate the conversion request as measured at the time the request for
      conversion is received.

            
	
              Funding

            	
              A
      minimum funding of $200,000 will occur upon signing of a binding letter of
      intent.  Thereafter, through March 31, 2010, as such date may be
      extended by up to 60 days in the discretion of the Company, the Company
      will continue to offer Notes in minimum increments of $25,000, up to a
      maximum funding of $500,000 in the aggregate.  Closings will
      occur as subscriptions are received.  Margie Chassman will use
      her best efforts to purchase any Notes not subscribed for, up to the
      maximum funding of $500,000, no later than March 31,
  2010.

            
	
              Adjustment
      to Other Securities

            	
              As
      part of the restructuring of the Company, which restructuring is
      contemplated as a tax-free reorganization predicated upon an agreed upon
      recapitalization, the warrants included in the Units sold by the Company
      in 2008 will be adjusted for original investors in the Units who fund at
      least $25,000 of the Notes, such that the aggregate exercise price for the
      Unit warrants will remain the same but the exercise price will be reduced
      to $.05 per share of common stock.  In addition, as part of the
      agreed upon recapitalization, the convertible debt held by Margie
      Chassman, up to an aggregate amount of $800,000 shall have its conversion
      price adjusted to $.01 per share.  Any existing convertible debt
      of the Company held by Margie Chassman in excess of $800,000, if any,
      shall have its conversion price adjusted to $.01 per share.  The
      Unit warrants and convertible debt held by Margie Chassman shall contain
      provisions permitting exercise or conversion only if as a result of any
      such exercise or conversion she would beneficially own no more than 4.99%
      of the common stock of the Company.

            
	
              Lock-Up

            	
              In
      connection with the recapitalization of the Company and the transactions
      contemplated hereby, Chassman has agreed to restrict her ability to
      transfer or sell any convertible notes, including those acquired through
      this financing, as well as the shares of Common Stock underlying such
      notes, for a period of two years from the date hereof, subject to the
      limitations and terms contained in the Lock_Up Agreement between Chassman
      and the Company in substantially the form  annexed hereto and
      made a part hereof as Schedule B.

            
	
              Registration
      Rights

            	
              Note
      purchasers will get piggyback registration rights for the common stock
      issuable upon conversion of the Notes.

            
	
              Compliance
      With Securities Laws

            	
              All
      parties acknowledge that neither the Notes, the convertible notes held by
      Chassman, nor the shares underlying the any such notes have been
      registered under the Act.  Accordingly, neither the Notes, the
      convertible notes held by Chassman, nor the common shares issuable upon
      conversion of the Notes may be sold, offered for sale, pledged or
      hypothecated in the absence of an effective registration statement under
      the Act covering the Notes or the common shares issuable upon
      conversion of the Notes under said Act or an opinion of counsel reasonably
      satisfactory to the Company that such registration is not
      required.

            

       

       

       

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

       

      	
              Proxy
      Statement 

            	
              Upon
      full funding of $500,000, and subject to the Company having sufficient
      wherewithal to cover the costs and expenses related thereto, including
      legal costs, the Company will use its best efforts to prepare and file a
      proxy statement with the SEC and to clear it for mailing and mail it to
      stockholders within 90 days of the signing of a binding letter of intent,
      to obtain stockholder approval for (i) an increase in the authorized
      common stock of the Company to 500 million shares;
      (ii)  obtaining authority to cause a reverse stock split for the
      Company’s common stock in the range of one share for each five to fifty
      shares outstanding; and (iii) amending the Company’s certificate of
      incorporation to include a blank check preferred stock authorization.
      Investor acknowledges and agrees that pending an increase in authorized
      common shares, any conversion and exercise rights shall be limited based
      on the current total of 50,000,000 authorized shares in the
      aggregate.

            
	
              Management
      Incentives

            	
              Investor
      agrees and acknowledges that, subject to Board approval, to be sought
      contemporaneously with approval of this Term Sheet, as part of the agreed
      upon recapitalization of the Company, management, together with certain
      angel investors, will receive anti-dilution protection with respect to
      their collective ownership interests that will enable management and the
      angel investors  to own or control a total of 49.44% of the
      Company on a fully diluted basis as described hereinbelow, of which
      management shall own or control  47.51% and the angel investors
      shall  own or control 1.93%.  Investor acknowledges
      and understands that, subject to Board approval, (i) management will be
      fully protected from dilution with respect to a combined 47.51% interest
      through the next $3.5 million in Net Funding (as defined below), and (ii)
      the angel investors will be fully protected from dilution through the
      completion of the financing being raised hereunder.  Set forth
      as Schedule C is a list of the breakdown of the management and angel
      investor percentages described above.

               

              As
      used herein, Net Funding means any single transaction or series of related
      transactions over a combined period of no more than twelve consecutive
      months which result in the Company receiving not less than $3.5 million in
      total funding within said  twelve month period, inclusive of
      this debt offering, net of all transaction costs, fees and other expenses
      associated with each capital raise, and net of interest, dividends, or
      other cash payments made in respect of the Notes and any notes payable to
      Margie Chassman. Notwithstanding the above, if during any 90 day period
      following the date hereof the Company fails to raise a minimum of $250,000
      in new money, as measured on a cumulative basis, then all Net Funding
      amounts received by the Company prior thereto will be excluded from the
      calculation for purposes of determining whether the Company has realized
      $3.5 million in Net Funding during any 12 month period.

               

              All
      anti-dilution protection for management and the angel investors shall be
      effectuated through the issuance of additional shares, options or other
      convertible securities, including preferred shares, as determined by the
      Board, and shall give effect to all dilutive securities issued by the
      Company, including the convertible Notes, as well as dilution caused
      through adjustment to the pricing of previously issued
      securities.   By way of clarification, upon issuance of any
      debt or equity securities which, through subsequent conversion or exercise
      of option or warrants, could result in the issuance of additional shares
      of Common Stock, or upon the approval of any adjustments to the conversion
      or exercise price of any previously issued securities, the anti-dilution
      rights in favor of management would thereupon be triggered and appropriate
      shares would be issued or subject to issuance, as the case may be,
      immediately upon issuance of such debt or equity
      securities.  Any shares issued, or subject to issuance, to
      management by virtue of its anti-dilution rights would be subject to
      clawback if and to the extent that the shares underlying any convertible
      debt securities, warrants, options or other securities which resulted in
      such issuance to management were to become conclusively unissuable in the
      future (e.g., upon the expiration of options and warrants,
      etc.).

            
	
              Counsel
      Fee for Investors

            	
              Andrew
      Levinson, counsel for the investors in the Notes, shall receive a fee of
      $15,000, of which half shall be payable upon the first closing and half
      shall be payable upon the final funding of $500,000 of Notes, in the
      aggregate.

            
	
              Board
      Approval

            	
              This
      term sheet shall remain subject to Board of Director approval which
      approval shall be sought immediately following the execution of this term
      sheet.

            

    

    

    IN WITNESS WHEREOF, the
parties hereto, intending to be fully bound by the terms and conditions of this
term sheet, have executed it or caused it to be executed by their duly
authorized representatives as of the day and year set forth above  at
the top of page one.

     

    MARGIE
CHASSMAN

     

    /s/ Margie Chassman                         

     

    OMNIMMUNE
HOLDINGS, INC.

     

    By:/s/ Harris
Lichtenstein               

     

    Harris A.
Lichtenstein, CEO

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    SCHEDULE
A

     

    

     

    FORM
OF CONVERTIBLE NOTE

     

    

     

    [Filed
Separately as Exhibit 10.2]

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    SCHEDULE
B

    
 

     

    LOCK-UP
AGREEMENT WITH MARGIE CHASSMAN

     

    

     

    [Filed
Separately as Exhibit 10.4]

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    SCHEDULE
C

    

    BREAKDOWN
OF PERCENTAGE OWNERSHIP INTERESTS OF OMNIMMUNE HOLDINGS, INC. SUBJECT TO
ANTI-DILUTION PROTECTION

    

    MANAGEMENT1

     

    
      	 	Harris
      Lichtenstein: 	14.17%
	 	Alex
      Krichevsky:	14.17%
	 	Mark
      Germain:  	13.62%
	 	Howard
      Becker: 	5.55%
	 	Total
      Management:  	                 
      47.51%2

    

     

     

    

    ANGEL
INVESTORS3                                    
       1.93
%

     

        TOTAL SHARES
SUBJECT TO

        ANTI-DILUTION
PROTECTION:           49.44%

     

    

     

    

     

    

      

    

      
      1
Anti-dilution protection to remain in place until Company
realizes  $3.5 million in Net Funding (as defined in the Term Sheet)
and is subject to Board Approval

       

    

      
      2 The 47.51 % total
percentage interest in favor of management represents the total percentage
ownership interest for management as part of the agreed upon recapitalization of
the Company.  While individual percentages may be adjusted, either
through agreement of management or through enforcement of individual contracts
with management personnel, the overall collective percentage ownership of the
Company in favor of management shall remain at 47.51% throughout the period
contemplated by the Term Sheet, with the final individual percentages to be
allocated or re-allocated, as the case may be, as agreed upon by management or
approved by the Board.

       

    

      
      3
Anti-dilution protection to remain in place through consummation of this
$500,000 Offering and is subject to Board Approval

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}]]